NCT07214428

Brief Summary

The goal of this trial is to investigate the effect of freeze-dried table grape powder (FTGP) on psychological distress and gut microbiota in college students. The main questions it aims to answer are: Does FTGP reduce anxiety, depression, and perceived stress? Does FTGP improve the gut microbiota? Researchers will compare FTGP to a placebo to see how FTGP affects psychological distress and gut microbiota. Participants will: Drink a daily supplement containing FTGP or a placebo for 4 weeks. Record consumption of grape powder or placebo in a compliance log. Complete surveys and provide stool samples. Three in-person visits.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
0mo left

Started Oct 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress90%
Oct 2025May 2026

First Submitted

Initial submission to the registry

October 1, 2025

Completed
8 days until next milestone

First Posted

Study publicly available on registry

October 9, 2025

Completed
11 days until next milestone

Study Start

First participant enrolled

October 20, 2025

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 30, 2026

Expected
Last Updated

January 15, 2026

Status Verified

January 1, 2026

Enrollment Period

2 months

First QC Date

October 1, 2025

Last Update Submit

January 14, 2026

Conditions

Keywords

Table grapeGut Microbiotapsychological distress

Outcome Measures

Primary Outcomes (3)

  • Hamilton Anxiety Scale -14

    HAMA-14 is one of the earliest and most widely used clinical scales for measuring the severity of a patient's anxiety. It has 14 items, each reflecting a cluster of anxiety symptoms. Total range: 0 to 56, with higher scores indicating greater severity of anxiety

    baseline (1st), week 4 (2nd) and week 5 (3rd)

  • 17-item of Hamilton Depression Rating Scale

    HAMD-17 is one of the most widely used clinician-administered scales for measuring the severity of a patient's depression. It has 17 items, each covering symptoms of depression across mood, physical, and cognitive domains. With higher scores indicating greater severity of depression.

    baseline (1st), week 4 (2nd) and week5 (3rd)

  • 10-item of Perceived Stress Scale

    PSS-10 is one of the most widely used psychological instruments for measuring the perception of stress. It has 10 items, each reflecting how unpredictable, uncontrollable, and overloaded respondents find their lives during the past month. Total range: 0 to 40, with higher scores indicating greater perceived stress.

    baseline (1st), week 4 (2nd) and week5 (3rd)

Secondary Outcomes (3)

  • Shannon Index of gut microbiota

    baseline (1st), week 4 (2nd) and week5 (3rd)

  • Beta diversity of gut microbiota

    baseline (1st), week 4 (2nd) and week 5 (3rd)

  • fecal short chain fatty acid

    baseline (1st), week 4 (2nd) and week5 (3rd)

Study Arms (2)

freeze-dried table grape powder (FTGP)

EXPERIMENTAL

Drink a daily supplement containing FTGP for 4 weeks

Dietary Supplement: freeze-dried table grape powder

Placebo

PLACEBO COMPARATOR

Drink a daily supplement containing a placebo for 4 weeks

Dietary Supplement: Placebo

Interventions

48g freeze-dried table grape powder/day for 4 weeks

freeze-dried table grape powder (FTGP)
PlaceboDIETARY_SUPPLEMENT

48g placebo/day for 4 weeks

Placebo

Eligibility Criteria

Age18 Years - 30 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 18-30 years old
  • Able to give written informed consent.
  • BMI 18.5-24.9 kg/m2
  • Healthy (self-reported)
  • Can read and speak English

You may not qualify if:

  • Currently taking medications that interfere with polyphenol
  • Currently using or have used antibiotics continuously for \>3 days within 3 months prior to enrollment
  • Have had surgery involving the intestinal lumen within the last 30 days
  • Have a documented diagnosis of celiac disease or/and inflammatory bowel diseases
  • Are pregnant or breastfeeding
  • Have prediabetes and diabetes
  • Have had bariatric surgery
  • Are immunocompromised ( e.g., cancer treatment, bone marrow/organ transplant, immune deficiency, or poorly controlled HIV/AIDS)
  • Are unable to provide consent
  • Are hospitalized,
  • Have a history of or current alcohol, drug, or medication abuse (self-reported),
  • Have contraindication to any substance in the investigational product or who are currently enrolled in other interventional trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Biochemistry and Microbiology, School of Environmental and Biological Sciences, Rutgers, The State University of New Jersey

New Brunswick, New Jersey, 08901, United States

Location

Study Officials

  • Guojun Wu

    Rutgers, The State University of New Jersey

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Research Professor

Study Record Dates

First Submitted

October 1, 2025

First Posted

October 9, 2025

Study Start

October 20, 2025

Primary Completion

December 24, 2025

Study Completion (Estimated)

May 30, 2026

Last Updated

January 15, 2026

Record last verified: 2026-01

Data Sharing

IPD Sharing
Will not share

IPD might not be shared according to the consent form.

Locations